image
Akero Therapeutics, Inc. AKRO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 28.09
-5.61 %
$ 1.96 B
Market Cap
-7.43
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-173 M OPERATING INCOME
-50.12%
Growth Rates
1Year -50.12%
3Years -29.20%
5Years -65.85%
7Years 0.00%
10Years 0.00%
-152 M NET INCOME
-35.46%
Growth Rates
1Year -35.46%
3Years -24.20%
5Years -13.18%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Akero Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 29 K
Gross Profit -29 K
Operating Expenses 173 M
Operating Income -173 M
Other Expenses -21.1 M
Net Income -152 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 29 K 0.3 0.2 0.2 0 0 0
Gross Profit 29 K (0.3) (0.2) (0.2) 0 0 0
OPERATING INCOME
Operating Expenses 172.9 115.2 100.9 80.2 45.7 13.8 4.6
Selling, General and Administrative Expenses 31.1 29.9 19.1 15.2 8.6 1.9 1.1
Research and Development Expenses 141.8 85.3 81.8 64.9 37.0 11.9 3.5
Operating Income (172.9) (115.2) (100.9) (80.2) (45.7) (13.8) (4.6)
PRE-TAX INCOME
Interest Income Expense 3.1 0.7 0 0 0 0 0
Total Other Income 21.1 3.1 0.1 0.9 1.9 (67.9) 0
Pre-Tax Income (151.8) (112.0) (100.8) (79.2) (43.8) (81.7) (4.6)
NET INCOME
Tax Provision 0 (3.1) 41 K 17 K 24 K (68.1) (5.0)
Net Income (151.8) (108.9) (100.7) (79.2) (43.8) (81.7) (4.6)
EPS 2.89 2.79 2.89 2.52 2.9 3.85 0.16